The shares of Elanco Animal Health Inc (ELAN) have recorded the market capitalization of 6.70B

The stock of Elanco Animal Health Inc (NYSE:ELAN) last traded at $13.56, down -2.73% from the previous session.

ELAN stock price is now -17.04% away from the 50-day moving average and -4.33% away from the 200-day moving average. The market capitalization of the company currently stands at $6.70B.

Top 5 Artificial Intelligence Stocks to Buy for 2024

By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it. According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."

Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"


With the price target enhanced from $13 to $20, Stifel Upgraded its rating from Hold to Buy for Elanco Animal Health Inc (NYSE: ELAN). On December 19, 2023, Jefferies recently initiated its ‘Buy’ rating on the stock quoting a target price of $17, while ‘Morgan Stanley’ rates the stock as ‘Overweight’

In other news, DOYLE WILLIAM F, Director bought 15,000 shares of the company’s stock on May 21 ’24. The stock was bought for $254,700 at an average price of $16.98. Upon completion of the transaction, the Director now directly owns 76,330 shares in the company, valued at $1.04 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Mar 08 ’24, Director DOYLE WILLIAM F bought 15,000 shares of the business’s stock. A total of $244,500 was incurred on buying the stock at an average price of $16.30. This leaves the insider owning 61,330 shares of the company worth $0.83 million. A total of 1.17% of the company’s stock is owned by insiders.

During the past 12 months, Elanco Animal Health Inc has had a low of $8.52 and a high of $18.80. As of last week, the company has a debt-to-equity ratio of 0.95, a current ratio of 3.29, and a quick ratio of 1.96. The fifty day moving average price for ELAN is $16.3554 and a two-hundred day moving average price translates $14.18275 for the stock.

The latest earnings results from Elanco Animal Health Inc (NYSE: ELAN) was released for 2024-03-31. The net profit margin was -29.83% and return on equity was -19.24% for ELAN. The company reported revenue of $1.21 billion for the quarter, compared to $1.26 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -4.14 percent.

Related Posts